Position in FOLD
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$6,469,577
+$2,804,031 QoQ
Shares Held
447,412
+73.8% QoQ
Ownership
0.142%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FOLD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Vestcor Inc holds $67,387,677 across 32 Biotechnology names. FOLD ranks #3 (9.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
34,019 | $15,190,844 | |
| 2 | INCY |
Incyte Corp
|
119,739 | $11,269,834 | |
| 3 | FOLD |
AMICUS THERAPEUTICS, INC.
This page
|
447,412 | $6,469,577 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
63,077 | $6,134,238 | |
| 5 | EXEL |
Exelixis, Inc.
|
138,065 | $5,921,607 | |
| 6 | TERN |
Terns Pharmaceuticals, Inc.
|
100,000 | $5,272,000 | |
| 7 | ACLX |
Arcellx, Inc.
|
19,578 | $2,247,945 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
5,319 | $1,759,897 |
All Filings in FOLD
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,469,577 | 447,412 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $3,665,546 | 257,412 | Shares | Sole | 2026-02-11 | |
| No filing history on record for this holder in this stock. | ||||||